BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 7054297)

  • 1. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Becker EL
    J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
    Fletcher MP; Seligmann BE; Gallin JI
    J Immunol; 1982 Feb; 128(2):941-8. PubMed ID: 6274963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.
    Marasco WA; Feltner DE; Ward PA
    J Cell Biochem; 1985; 27(4):359-75. PubMed ID: 2987275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM; Huang CK; Becker EL
    J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
    Borish L; O'Reilly D; Klempner MS; Rocklin RE
    J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
    Rotrosen D; Malech HL; Gallin JI
    J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU; Wissler JH; Damerau B
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L; Aksamit RR
    J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors.
    Weisbart RH; Golde DW; Gasson JC
    J Immunol; 1986 Dec; 137(11):3584-7. PubMed ID: 3491142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes.
    Lohr KM; Snyderman R
    J Immunol; 1982 Oct; 129(4):1594-9. PubMed ID: 6286769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
    Dentino AR; Raj PA; De Nardin E
    Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes.
    Seligmann BE; Fletcher MP; Gallin JI
    J Immunol; 1983 Apr; 130(4):1902-9. PubMed ID: 6131922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH; Kay AB
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
    Geha RS
    J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.